Given the advantages over its rivals, Regeneron is hopeful its bispecific antibody will become the new standard of care for ...

A new data analysis adds to the mounting evidence that abortion bans have made the common experience of first-trimester ...

A B-cell maturation antigen (BCMA)-directed bispecific antibody, linvoseltamab is indicated for adult patients who have ...

Fetal personhood bills have been introduced in 27 states. No, the anti-choice movement is not just declaring victory.

Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) today announced that the U.S. Food and Drug Administration (FDA) has granted accelerated approval for Lynozyfic™ (linvoseltamab-gcpt) to treat adult ...

Regeneron Pharmaceuticals (NASDAQ:REGN) saw its stock increase by 2.8% after the U.S. Food and Drug Administration granted ...

Investing.com -- Regeneron Pharmaceuticals (NASDAQ: REGN) stock rose 2.8% after the U.S. Food and Drug Administration granted accelerated approval for the company’s blood cancer therapy Lynozyfic.

The FDA approved Lynozyfic for relapsed multiple myeloma, but serious risks require restricted use under a special safety program.

While Louisiana lawmakers did little to make your life better this year, they made sure to protect themselves and big ...

Veronica told Newsweek: "I want them to love one another as much as my sister and I love each other. Having a sister is just so special." ...

Adriana Smith’s body was kept on life support for 16 weeks so her fetus could gestate. Abortion politics don’t capture the ...